Karalyne Crowder is a Principal Scientist at Pfizer with twenty years of experience in nonclinical research, including fifteen years as a Study Director specializing in toxicology and drug metabolism studies. Karalyne has extensive knowledge of Good Laboratory Practices (GLP), regulatory writing, and project management, along with expertise in pharmacokinetic analysis using WinNonlin. Previously, Karalyne held roles at Altasciences and Alder Biopharmaceuticals Inc., and is currently a Senior Staff Scientist at Seagen. Karalyne earned a Bachelor of Science in Biology from Fordham University.
This person is not in any teams
This person is not in any offices